Cidara Therapeutics Inc
General ticker "CDTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $138.0M
Cidara Therapeutics Inc follows the US Stock Market performance with the rate: 14.8%.
Estimated limits based on current volatility of 4.8%: low 21.66$, high 23.82$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.32$, 21.86$]
- 2024-12-30 to 2025-12-30 estimated range: [6.30$, 16.81$]
Financial Metrics affecting the CDTX estimates:
- Negative: Non-GAAP EPS, $ of -4.19 <= 0.10
- Negative: Operating profit margin, % of -27.70 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -25.76 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.12
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term CDTX quotes
Long-term CDTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $49.57MM | $64.29MM | $63.91MM |
| Operating Expenses | $91.83MM | $94.01MM | $88.39MM |
| Operating Income | $-42.26MM | $-29.72MM | $-24.48MM |
| Non-Operating Income | $-0.21MM | $0.19MM | $2.00MM |
| Interest Expense | $0.21MM | $0.00MM | $0.00MM |
| R&D Expense | $73.09MM | $75.52MM | $68.53MM |
| Income(Loss) | $-42.47MM | $-29.53MM | $-22.49MM |
| Taxes | $0.00MM | $0.27MM | $0.44MM |
| Profit(Loss) | $-42.47MM | $-29.80MM | $-22.93MM |
| Stockholders Equity | $21.57MM | $-2.90MM | $-8.21MM |
| Inventory | $2.59MM | $0.00MM | $6.10MM |
| Assets | $75.33MM | $47.59MM | $67.03MM |
| Operating Cash Flow | $-25.23MM | $-28.47MM | $-22.43MM |
| Capital expenditure | $0.04MM | $0.12MM | $0.51MM |
| Investing Cash Flow | $-0.04MM | $-0.12MM | $-0.51MM |
| Financing Cash Flow | $44.60MM | $-0.95MM | $25.98MM |
| Earnings Per Share* | $-16.75 | $-8.53 | $-5.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.